|Videos|October 29, 2021
Diet and Comorbidities in Multiple Sclerosis: Mona Bostick, RDN, LDN, MSCS
Author(s)Mona Bostick, RDN, LDN, MSCS
The registered dietitian at Food Matters 365 in Greensboro, North Carolina, discussed the role nutrition can play in treating comorbidities, sharing her thoughts on popular elimination diets. [WATCH TIME: 2 minutes]
Advertisement
WATCH TIME: 2 minutes
“At this point, although there is no therapeutic diet that has been shown by science to directly impact the disease process itself, comorbidities are where nutrition can have an enormous impact. My presentation addressed the role of registered dietitians using nutrition interventions to treat and manage comorbid health conditions, and there's a lot of evidence that suggests that by managing those conditions well, we can improve the health outcomes of people with multiple sclerosis.”
Nutrition has been shown to play an integral part in the management of multiple sclerosis (MS), specifically in patients with comorbidities. At the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) , October 25-28, Mona Bostick, RDN, LDN, MSCS, founder, Food Matters 365, Greensboro, North Carolina, gave a presentation entitled, “The Importance of Assessing Nutritional Health in Patients with Multiple Sclerosis,” later sitting down with NeurologyLive to discuss the key takeaways.
Bostick commented on nutrition’s ability to impact comorbidities for this patient population, noting that there are currently no therapeutic diets that have been proven to alter the disease process of MS. She further provided her thoughts on popular elimination diets, adding that these too have no clinical evidence to validate them. Noting that some patients do report that diet may help to manage symptoms, she cautioned patients to run alterations by the healthcare team to avoid “unintended consequences” from different approaches.
For more coverage of CMSC 2021, click here .
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
2
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
3
NeurologyLive® Brain Games: September 14, 2025
4
2025 Women in Neurology Conference: Educating, Mentoring, and Networking
5